A detailed history of Sg Americas Securities, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 13,566 shares of YMAB stock, worth $112,326. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,566
Holding current value
$112,326
% of portfolio
0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$9.95 - $15.39 $134,981 - $208,780
13,566 New
13,566 $178,000
Q1 2024

May 06, 2024

SELL
$6.57 - $18.69 $63,045 - $179,349
-9,596 Reduced 44.51%
11,963 $195,000
Q4 2023

Jan 12, 2024

BUY
$4.88 - $7.42 $15,664 - $23,818
3,210 Added 17.49%
21,559 $147,000
Q3 2023

Oct 13, 2023

BUY
$4.86 - $7.23 $89,176 - $132,663
18,349 New
18,349 $100,000
Q1 2023

Apr 28, 2023

BUY
$2.83 - $5.11 $33,043 - $59,664
11,676 Added 116.08%
21,735 $109,000
Q4 2022

Feb 02, 2023

SELL
$3.0 - $15.17 $19,449 - $98,347
-6,483 Reduced 39.19%
10,059 $49,000
Q3 2022

Oct 31, 2022

SELL
$13.96 - $19.67 $23,383 - $32,947
-1,675 Reduced 9.19%
16,542 $239,000
Q2 2022

Jul 29, 2022

BUY
$8.22 - $15.13 $149,743 - $275,623
18,217 New
18,217 $276,000
Q1 2022

Apr 29, 2022

SELL
$6.55 - $17.42 $98,381 - $261,648
-15,020 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$15.51 - $29.31 $167,352 - $316,254
-10,790 Reduced 41.81%
15,020 $243,000
Q3 2021

Nov 01, 2021

BUY
$27.47 - $37.31 $10,273 - $13,953
374 Added 1.47%
25,810 $737,000
Q2 2021

Aug 12, 2021

SELL
$25.45 - $37.64 $94,928 - $140,397
-3,730 Reduced 12.79%
25,436 $860,000
Q1 2021

May 13, 2021

SELL
$29.16 - $51.96 $803,241 - $1.43 Million
-27,546 Reduced 48.57%
29,166 $882,000
Q4 2020

Feb 04, 2021

SELL
$37.86 - $54.26 $786,503 - $1.13 Million
-20,774 Reduced 26.81%
56,712 $2.81 Million
Q3 2020

Nov 09, 2020

BUY
$35.13 - $43.62 $2.54 Million - $3.15 Million
72,163 Added 1355.68%
77,486 $2.98 Million
Q2 2020

Jul 20, 2020

SELL
$23.66 - $49.53 $4,968 - $10,401
-210 Reduced 3.8%
5,323 $230,000
Q1 2020

Apr 30, 2020

BUY
$14.39 - $35.8 $30,952 - $77,005
2,151 Added 63.6%
5,533 $144,000
Q4 2019

Jan 28, 2020

BUY
$23.81 - $33.78 $80,525 - $114,243
3,382 New
3,382 $106,000

Others Institutions Holding YMAB

About Y-mAbs Therapeutics, Inc.


  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $362M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.